Cargando…
Intrapulmonary Vaccination Induces Long-lasting and Effective Pulmonary Immunity Against Staphylococcus aureus Pneumonia
BACKGROUND: Staphylococcus aureus causes community- and hospital-acquired pneumonia linked to a high mortality rate. The emergence and rapid transmission of multidrug-resistant S. aureus strains has become a serious health concern, highlighting the challenges associated with the development of a vac...
Autores principales: | Fan, Xin, Li, Ning, Xu, Meiyi, Yang, Decheng, Wang, Beinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408773/ https://www.ncbi.nlm.nih.gov/pubmed/33417695 http://dx.doi.org/10.1093/infdis/jiab012 |
Ejemplares similares
-
Vaccine protection against Staphylococcus aureus pneumonia
por: Wardenburg, Juliane Bubeck, et al.
Publicado: (2008) -
Staphylococcus aureus Manganese Transport Protein C Is a Highly Conserved Cell Surface Protein That Elicits Protective Immunity Against S. aureus and Staphylococcus epidermidis
por: Anderson, Annaliesa S., et al.
Publicado: (2012) -
Benefits of Aerosolized Phages for the Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus: An Experimental Study in Rats
por: Prazak, Josef, et al.
Publicado: (2021) -
High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis( )
por: McCallum, Andrew D, et al.
Publicado: (2022) -
Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STaphylococcus aureus suRgical Inpatient Vaccine Efficacy (STRIVE) Randomized Clinical Trial
por: Hassanzadeh, Hamid, et al.
Publicado: (2023)